Special Issue "Marine Compounds and Inflammation"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 April 2013).
Interests: marine natural products; structure elucidation; chemical proteomics; target discovery; bioorganic chemistry
Special Issues, Collections and Topics in MDPI journals
Oceans cover about 70% of the earth’s surface and marine organisms comprise approximately a half of the total biodiversity. Marine natural products possess a unique chemical diversity and have evolved for optimal interactions with biological macromolecules, constituting an enormous library of novel compounds with wide biological properties useful in the drug discovery process.
The search for new drugs is currently moving toward a rationalization in which chemistry and pharmacology are joined into a targeted approach to drug discovery, focused on specific diseases and molecular targets. In this context, inflammation is increasingly considered a crucial biological pathway, due to its involvement in a large number of diseases such as allergies, asthma, rheumatoid arthritis, inflammatory bowel diseases, atherosclerosis, and in particular in the initiation and progression cancer, strictly implicated in many inflammatory processes such as increased angiogenesis and DNA synthesis, genomic damage, cellular proliferation, disruption of DNA repair pathways, and inhibition of apoptosis. On this basis, the exploration of marine sources in search of novel chemical scaffolds for the treatment of inflammatory-driven diseases represents a key pharmacological goal.
As the Guest Editor, I would like to invite scientists to report their findings in the field of marine anti-inflammatory compounds.
Prof. Dr. Agostino Casapullo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- marine natural products
- transcription factors
- drug discovery
- anti-inflammatory effects
- bioactive compounds
- marine pharmaceuticals
- autoimmune diseases
- intracellular signaling pathways